Phase 3 Colorectal Cancer Trial, Recruiting NCT05179889 Sponsor: Chungnam National University Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Phase 3 Colorectal Cancer Trial, Recruiting

NCT05179889
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 20 and 70 years old and are generally able to carry out daily activities with minimal limitations, OR you are between 71 and 75 years old and fully able to carry out all normal daily activities without any restrictions
  • Your colon cancer has been confirmed by a lab test to be a specific type (adenocarcinoma) at an advanced stage (high-risk Stage III), meaning it has grown through the colon wall and/or spread to nearby lymph nodes
  • You had surgery to completely remove the cancer (with no cancer cells left at the edges) within the last 60 days before joining the trial
  • Your blood counts, liver, and kidney are working well enough, based on recent blood tests (confirm with trial site for specific numbers)
  • You are willing and able to read, understand, and sign a consent form agreeing to take part
  • Your doctors expect you to live for at least 5 more years

Who may not be able to join:

  • Your cancer has spread to distant parts of the body (for example, the liver or lungs)
  • You have cancer in the middle or lower part of the rectum that would require radiation therapy
  • You had serious complications after your surgery (rated Grade 3 or higher on a standard medical scale) (confirm with trial site)
  • You have another health condition or post-surgery issue that makes chemotherapy unsafe for you
  • You have had a known allergic reaction to any of the treatments used in this trial
  • You have a hereditary condition linked to colon polyps or colorectal cancer (such as FAP or Lynch syndrome)
  • You have inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • You have had another type of cancer in the past that could not be fully cured
  • You are currently pregnant or breastfeeding
  • Your doctor believes there is any other reason that would make it unsafe or unsuitable for you to join the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Sponsor
Chungnam National University Hospital
Registry
ClinicalTrials.gov
Start date
6 July 2021
Est. completion
5 July 2028

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Disease free survival (DFS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov